Cooperman Leon G’s Elevance Health ELV Stock Holding History

Cooperman Leon G’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-227,900	Closed	-$66.7M	–	41
2026 Q1	$66.7M	Sell	227,900 -113,000	-33%	-$37.1M	2.19%	16
2025 Q4	$120M	Hold	340,900	–	–	3.96%	8
2025 Q3	$110M	Buy	340,900 +60,000	+21%	+$18.7M	3.44%	8
2025 Q2	$109M	Buy	280,900 +2,500	+0.9%	+$1.01M	3.84%	7
2025 Q1	$121M	Hold	278,400	–	–	4.81%	5
2024 Q4	$103M	Buy	278,400 +107,400	+63%	+$44.9M	3.89%	10
2024 Q3	$88.9M	Buy	171,000 +41,000	+32%	+$21.9M	3.78%	10
2024 Q2	$70.4M	Hold	130,000	–	–	2.97%	14
2024 Q1	$67.4M	Hold	130,000	–	–	2.81%	16
2023 Q4	$61.3M	Buy	130,000 +11,860	+10%	+$5.48M	2.92%	15
2023 Q3	$51.4M	Buy	118,140 +58,140	+97%	+$26.4M	2.69%	15
2023 Q2	$26.7M	Buy	+60,000	New	+$27.7M	1.45%	22

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cooperman Leon G's ELV Position: Q2 2026 in Review

Cooperman Leon G sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 227,900 shares — an estimated $66.7M sold.

Cooperman Leon G first reported a position in ELV in Q2 2023 and held it in 12 quarters. The position peaked at $121M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Cooperman Leon G reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Cooperman Leon G sold 227,900 Elevance Health shares in Q2 2026, an estimated $66.7M.
Cooperman Leon G first reported a position in Elevance Health in Q2 2023 and held it in 12 quarters.
Cooperman Leon G's Elevance Health position peaked at $121M in Q1 2025.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cooperman Leon G's 13F filing for Q2 2026, filed 14 Aug 2026.